Sanne van den Berg graduated in 2007 as biomedical scientist from Radboud University in Nijmegen. After her studies, Sanne started with her PhD project at Erasmus University Medical Center Rotterdam, department of Medical Microbiology and Infectious Diseases. In 2015, she obtained her PhD with focus on improvement of diagnosis and treatment of Staphylococcus aureus infections using experimental studies. Subsequently, she became employed as post-doctoral researcher at same department. Her research aimed to optimize the use of antimicrobials in the clinical setting and to prevent antimicrobials resistance. The rapid and ongoing spread of antimicrobial-resistant bacteria is considered a global threat. It is of utmost importance that we do everything we can both to slow the spread of resistance, and to ensure that we are able to mitigate its impact with effective new treatments to replace those that it renders obsolete. Sanne’s studies support this by studies on pharmacokinetics (PK) and pharmacodynamics (PD) of antimicrobials including the preclinical spectrum. Since 2019, Sanne is the principal investigator in the PK/PD workgroup.
Field(s) of expertise
Preclinical studies on pharmacokinetics and pharmacodynamics of antimicrobials.
Click here to view the publications of Sanne van den Berg.
Sanne van den Berg has supervised and supervises bachelor students. She has been teaching at the Research Master’s program ‘Infection and Immunity’ of the Erasmus MC Postgraduate School Molecular Medicine.